Instrument Inactif

Cours Rennova Health Inc Nasdaq

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17/07/20
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29/06/20
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16/06/20

Dirigeants	Titre	Age	Depuis
Darrell Peterson CEO	Chief Executive Officer	65	14/05/23
Gerard Dab CHM	Chairman	75	14/05/23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Administrateurs	Titre	Age	Depuis
Gerard Dab CHM	Chairman	75	14/05/23
Sharon Hollis CEO	Chief Executive Officer	47	01/07/11
Francisco Roca BRD	Director/Board Member	58	14/05/23

Secteur

	Varia. 1 janv.	Capi.
SONIC HEALTHCARE LIMITED	-16,49 %	8,25 Md
RADNET, INC.	+40,93 %	3,58 Md
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-35,59 %	2,46 Md
SYNLAB AG	-7,88 %	2,46 Md
DR. LAL PATHLABS LIMITED	-8,95 %	2,38 Md
NEOGENOMICS, INC.	-5,93 %	1,81 Md
FLEURY S.A.	-18,96 %	1,55 Md
DIAN DIAGNOSTICS GROUP CO.,LTD.	-38,35 %	1,21 Md
METROPOLIS HEALTHCARE LIMITED	+6,91 %	1,11 Md